Objective: To determine the diagnostic accuracy and prognostic value of 18 FDG-PET in a recent series of patients operated for intractable partial epilepsy associated with histologically proven Taylor-type focal cortical dysplasia (TTFCD) and negative MRI.
Focal cortical dysplasias (FCDs) represent one of the most frequent pathologies in epilepsy surgery after hippocampal sclerosis and tumors. In large multicenter cohorts, FCDs were identified in 14% of patients 1 and 42% in pediatric series. 2 Taylor-type focal cortical dysplasia (TTFCD), first described in 1971, 3 corresponds to severe FCD (type II A-B) according to recent classifications. 4 Although TTFCD represents no more than a third of FCD subtypes, [5] [6] [7] [8] [9] the unmistakable features of giant dysmorphic neurons with or without balloon cells correspond to a homogeneous pathology, providing a greater consensus than other FCD subtypes. 10, 11 It is well-established that the main predictor of favorable surgical outcome is complete removal of the dysplastic cortex. 2, 9, [12] [13] [14] [15] [16] [17] Since TTFCDs are predominantly located in extratemporal areas, especially in the frontocentral region, and often involve eloquent cortex, 2, 12, 14, [18] [19] [20] [21] [22] accurate assessment of the lesional extent is crucial to improve functional and seizure outcome. Typical MRI features have been widely described, but subtle lesions remain difficult to detect even with optimal imaging. So-called negative MRI is reported in 17% to 34% of cases in recent series 2, 5, 8, 15, [23] [24] [25] and poor surgical outcome is mostly obtained in these cryptogenic cases. 15, [24] [25] [26] The aim of the present study is to evaluate the ability of 18 FDG-PET to detect the dysplastic cortex, to localize the epileptogenic zone (EZ), and to improve the surgical outcome in a recent exhaustive series of patients with TTFCD and negative MRI.
METHODS Among 56 consecutive patients operated during the last decade in our institution for intractable epilepsy and histologically proven TTFCD, 23 (12 male, 8 children) had negative MRI (41%). Age at epilepsy onset ranged from 2 to 14 years (mean 6.5), age at operation from 7 to 38 years (mean 17.5), and preoperative duration of epilepsy from 1 to 26 years (mean 11). Severe partial epilepsy was reported in all; 20 patients had daily seizures (up to 30 a day). All exhibited stereotyped seizures and ictal semiology highly suggestive of a well-localized cortical area. Presurgical evaluation included ictal video-EEG, high-resolution MRI, functional MRI, and 18 FDG-PET scan for all patients. In addition, 21 underwent stereo-EEG (SEEG).
Imaging data. MRI scans were performed on a 1.5-T Magnet (Signa Excite, General Electric) including 3-dimensional T1-weighted, 1.2-mm-thick contiguous slices, coronal T2-weighted, and fluid-attenuation inversion recovery (FLAIR) sequences. All MRIs were reviewed by a trained radiologist blind to the PET results and localization of the lesion. 18 FDG-PET examination was done using either a head-dedicated PET camera with 5.8 mm in-plane and 5-mm axial resolution (ECAT 953/31B Siemens: 5 patients) or a 3-dimensional camera allowing axial sampling of 2.46 mm (HR ϩ CTI Exact Siemens). 18 FDG was injected IV at a mean dose of 220 MBq/70 kg body weight. Reconstructed images were corrected for attenuation using transmission scans obtained from a germanium source. No patient had other seizure than the usual type (i.e., secondary generalized) during the 7 days preceding PET. Ten patients had ictal event less than 6 hours before and 4 during the PET scan. However, seizures were brief (less than 30 seconds) and data were interpretable in all but one subject, in whom PET was repeated. Visual PET analysis was performed by a trained examiner during the presurgical phase and before SEEG procedure, using a colored scale allowing detection of metabolic changes, each color corresponding to a 15% variation of FDG uptake. Extent of hypometabolic areas was classified as focal (Յ3 cm) or regional (Ͼ3 cm). PET and MRI were routinely coregistered using ANATOMIST software (SHFJ, CEA, Orsay, France). In addition, individual statistical analysis using SPM5 software (Welcome Department of Cognitive Neurology, London, UK) was secondarily performed. Normalization and smoothing of 18 FDG-PET images were done using a homemade adult template. The parametric image of each patient was compared to that of a group of 30 healthy subjects using a t test analysis. The p value was fixed at 0.005 and a 20-voxel correction was applied.
Standard protocol approvals, registrations, and patient consents. PET scans were performed as a research protocol approved by the local ethics committee (CCPPRB Pitié-Salpêtrière, Paris, France) and written informed consent was obtained.
Neurophysiologic data. SEEG data were analyzed as previously reported. 12, 27, 28 In the present series, the placement of intracranial electrodes took into account visual PET data, allowing prospectively analysis of the electrical pattern that displayed hypometabolic areas. Colocalization between hypometabolism and EZ was defined by a strict concordance between ictal onset zone and hypometabolic areas.
Histology. Cortical samples were fixed in formalin-zinc. Paraffin sections (4 m) were stained by Hemalun-Phloxin and Nissl-Luxol (Kluver-Barera). Complementary immunohistochemistry was done using antibodies directed against glial fibrillary acid protein (clone 6F2, Dakocytomation), microtubule-associated proteins (clone HM-2, Sigma), and neuronal nuclei (clone A60, Millipore-Chemicon).
The cortical specimens were labeled according to the location of intracranial electrodes. Histologic findings in cortical samples were compared to SEEG, MRI, and metabolic data. Hypometabolic areas were considered to be colocalized with dysplastic tissue when they were confined to pathologic areas and more extensive when observed in lesional, perilesional, and distant areas. TTFCD was considered as completely removed if the pathologic tissue was totally included in the resection.
RESULTS MRI was normal in 13 patients whereas subtle gyral abnormalities were found in 10 others, such as unusual gyral depth or sulci patterns (8 patients) or mild blurring of gray and white matter demarcation without any signal change on T2 or FLAIR sequences (2 patients). These findings were regarded as nonspecific or doubtful and therefore the MRI was considered negative (figures e-1 and e-2 on the Neurology ® Web site at www.neurology.org).
Visual PET data. Visual analysis of PET scan imaging detected a focal or regional hypometabolism in 18 cases (78%). Whether hypometabolism was focal (9 cases) or regional (9 cases) was not determined by MRI findings (table 1) . Superimposition of PET on MRI allowed precise anatomic correlates. Focal hypometabolism colocalized with a single gyrus or part of a gyrus in all 9 cases. The most limited hypometabolisms corresponded to the most localized TTFCDs in the depth of the sulcus (figure 1). Negative PETs (5 cases) corresponded to small TTFCDs located in regions difficult to analyze (i.e., medial part of the central area, insula) or to some unusual gyral pattern extending deeply into the white matter. In 4 of these 5 patients, TTFCDs were detected after superimposition of PET on MRI (figure 2). Regional hypometabolism (9 cases) corresponded to part of a lobe or part of 2 adjacent lobes (i.e., temporofrontal, frontoinsular, parieto-central, or occipito-temporal). These intralobar or multilobar cortical areas included maximal hypometabolism areas surrounded by mild to moderate decrease of metabolism and corresponded to several gyri (figure 3). PET/MRI coregistration was positive in all but one case that showed a doubtful area of focal hypometabolism in the parietal lobe, near the convexity. Therefore, 18 FDG-PET contributed to TTFCD identification in 22 of the 23 MRI-negative cases (95%).
SPM PET data. SPM analysis was performed in the 18 patients who were investigated with the 3-dimensional camera. Significant hypometabolic areas were detected in 16 cases (89%) and a concordance with visual analysis was found in 13 ( figure 3 and figure e-3). The 2 negative SPM findings corresponded to unusual gyral patterns extending deeply into the white matter. For these cases, visual analysis was more helpful than SPM. In the 3 nonconcordant cases, multiple hypometabolic areas were detected by SPM, including the visually assessed hypometabolic areas. Since no predominant area was found, SPM seemed of less localizing value. Therefore, in 13/18 cases (72%), SPM provided valuable information regarding the maximal site of hypometabolism and additional arguments to delineate the dysplastic lesion.
Hypometabolism and SEEG correlations. Intralesional recordings including hypometabolic areas were obtained in 18 cases (31 intralesional electrodes, 1 to 3 per patient). Continuous (15 cases) or discontinuous (3 cases) rhythmic spike discharges (RSDs) characteristic of TTFCD 12 were recorded within the hypometabolic gyrus. For electrodes located close to but not within the hypometabolic areas (3 cases), the pattern was atypical with lack of rhythmic spiking and persistence of background activity. Hypometabolic gyri or cortical areas displaying RSDs also corresponded to the site of ictal onset (57 seizures in 17 patients). Electrical stimulations within the hypometabolic areas elicited usual seizures (46 seizures in 17 patients). In all cases, the postictal depression of activity correlated with ictal onset zone and was clearly related to maximal hypometabolic areas (figure 4) . Correlations between hypometabolic areas and EZ (20 patients) demonstrated that EZ colocalized with a hypometabolic gyrus in 11 cases whereas it was included within a more extensive hypometabolism in the 9 others. Similar results were found with visual and SPM analysis, both being less localizing than PET/MRI coregistration, which provided the best degree of concordance with EZ. Notable was a misleading predominant temporal hypometabolism found in 2 cases of medial anterior frontal TTFCD.
Location of TTFCDs and surgical results. TTFCDs were located in extratemporal areas in all cases. Involvement of frontal or central functional areas (such as frontal posterior premotor areas, precentral, central, or postcentral regions, and insular or Broca areas) was predominant (15 patients, 65%). The extent of surgical resection, based on neurophysiologic and imaging results including PET data, was limited to a gyrectomy (12 cases), whereas a corticectomy was performed in the 11 others. The 10 patients operated in premotor, precentral, central, or postcentral regions who developed postoperative sensory-motor deficits totally recovered. Hemianopsia that affected one patient after occipital resection persisted. With a mean follow-up of 4 years, Engel Class I was obtained in 20 patients (87%), and Class IA in 13 (56%). All 10 patients with subtle gyral abnormalities and positive PET obtained Class I outcome (9 out of 10 in Class IA, including the 2 patients operated without SEEG), whereas outcome in patients with normal MRI appeared somewhat less favorable, 10 patients being in Class I (77%) and only 4 of them in Class IA.
Neuropathology. Histologic findings demonstrated typical features of TTFCD in all cases including balloon cells in 19 (82%). Dysplastic cortex was always observed within the hypometabolic areas, although areas exhibiting giant dysmorphic neurons were only seen in a part of the hypometabolic gyri. Interestingly, abnormal cortical organization was also seen in areas surrounding the abnormal cells, possibly contributing to the metabolic Concordance/visual analysis 7 6
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changes (figure 3)
. Very small dysplasias with few abnormal neurons located at the bottom of a sulcus affected 8 patients (35%) (figure 1). Such "microscopic" lesions would probably be undetectable even on highresolution MRI. However, larger forms involving several gyri were also found (4 patients). Extent of the lesional resection could be assessed in 19 cases and was considered complete in 16. In 4 other cases, the specimens were fragmented and margins of the resections were difficult to analyze. Surgical failure was related to incomplete lesional resection.
FDG-PET.
18 FDG-PET (table e-1) proved to have high sensitivity (78%) for TTFCD detection in negative MRI cases that was increased using PET/MRI coregistration (95%). In 55% of the cases, hypometabolic areas and EZ colocalized: hypometabolism was focal and corresponded to a single gyrus. In the other cases, regional hypometabolic areas also included EZ, but were more extensive. Findings provided by SPM analysis were mostly consistent with visual findings although slightly less accurate or reliable. Using PET/MRI coregistration, we found that
Figure 1 MRI (coronal T1 and T2 slices, surface coil) and 18 FDG-PET coregistered on MRI (coronal and axial slices) in a left precentral Taylor-type focal cortical dysplasia (TTFCD)
Contrasting with lack of any abnormal finding on MRI, focal hypometabolism is easily visually detected and corresponds to a single gyrus (arrow). Cortical specimen (A, F, G: Klüver-Barrera; B, C, D: microtubule-associated proteins; E: glial fibrillary acid protein immunostaining). No macroscopic abnormalities may be detected at low magnification (A). Note the presence of a Virchow-Robin space in contact with the gyrus, also visible on MRI. However, typical features of TTFCD, including dysmorphic giant neurons (B, C, D, F) and balloon cells (E, G), are observed at the bottom of the sulcus and in the underlying white matter (original magnification: A ϫ4, B ϫ10, C ϫ15, E ϫ20, D-G ϫ40). This case corresponds to one of the 8 "microscopic" forms described in this series. The patient is seizure-free for 7 years after this focal resection and stopped antiepileptic drugs for 4 years.
Figure 2 T1 sequence MRI, 18 FDG-PET, and PET/MRI superimposition (axial view)
MRI shows an unusual gyral pattern in premotor right area; however, visual examination does not detect any asymmetry of metabolism. PET/MRI superimposition allows recognizing a gyral hypometabolism corresponding to epileptogenic zone and Taylor-type focal cortical dysplasia with balloon cells. After a resection limited to this gyrus, the patient is seizure-free for 3 years and now stopping antiepileptic drugs.
18 FDG-PET reached a predictive value for seizure freedom of 86%.
DISCUSSION In a series of 23 patients with negative MRI, we demonstrate that FDG-PET/MRI coregistration contributes to the identification of TTFCD in 95% of the cases, leading to excellent surgical results. We included in negative MRI findings of doubtful significance (i.e., subtle gyral abnormalities) that subsequently correlated with hypometabolic areas and proved to correspond to dysplastic tissue. We emphasize that correlation between both imaging methods can be used to confirm that a suspected minor gyral abnormality indeed represents a TTFCD. Such negative MRI cases, with either normal or near-normal imaging, represent 41% of patients operated for a TTFCD during the last decade in our institution. This is the largest series reported to date, as previous ones did not exceed 10 patients. 5, 26, 29 Extratemporal location, involving eloquent cortex in 65%, was characteristic of our population. In contrast with other series that usually report a poor outcome in cryptogenic extratemporal epilepsy, our seizure-free outcome rate reaches 87%. We assume that it results from the improved detection and delineation of TTFCDs provided by MRI/ 18 FDG-PET A regional right precentral and premotor hypometabolism is visually detected and concordant with SPM 5 results. Cortical specimen (A-E, Klüver-Barrera): Macroscopic examination shows an unusual gyral pattern also seen on MRI (A ϫ4). Several gyri are involved by the dysplastic lesion, consisting of giant neurons (B ϫ40) and balloon cells (C ϫ40) patch alternating with areas of cortical disorganization without abnormal cells (D ϫ20). In the same specimen, areas of "severe" dysplasias are therefore mixed with areas of "mild" dysplasias. The patient is seizure-free for 5 years without any permanent deficit.
coregistration in negative MRI cases, in addition to SEEG recordings. In cryptogenic neocortical epilepsy, surgical results are usually reported less favorable than for medial temporal lobe epilepsy or lesional epilepsy. In most instances, seizure-free outcome ranges from 37% to 47% of the cases. [24] [25] [26] Better results (65% of seizure-free patients) have been recently reported in a series using SEEG to localize the EZ. 29 Interestingly, FCD was found in about 40% of negative MRI cases in this study. However, other FCD series including negative MRI cases showed less favorable results with a rate of seizure freedom between 32% and 46%. 15, 17, 30, 31 In contrast, for most series of MRI-detected TTFCDs, outcome is much better, seizure freedom being obtained in 60%-80% 5, 6, 17, 20, 21, 32 and up to 90% in some selected cases. [9] [10] [11] [12] [13] Despite improvement during the last decade, surgery for TTFCDs remains a challenge. The main predictor of surgical failure is reported to be incomplete resection of the dysplastic cortex, whether it results from inappropriate assessment of its limits or involvement of functional areas. 2, 9, [15] [16] [17] 19, 31 With 87% of seizure freedom despite negative MRI and frequent location in eloquent cortex, our results show the additional value of 18 FDG-PET included in the presurgical workup. By comparison, in our first series of patients mainly operated before the era of modern imaging, and therefore similar to this negative MRI series, 64% of patients became seizurefree. 12 Since the location of TTFCDs and neurophysiologic investigations were the same in both series, improvement of outcome is most likely to result from the systematic use of 18 FDG-PET before planning SEEG and cortical resection.
Despite intensive expertise, best-practice MRI sequences, and new high-field MRI (3 Tesla), all centers report missed TTFCD cases. 10,33 18 FDG-PET is reported to have a high sensitivity to detect TTFCDs with areas of hypometabolism in 60% to 92%. 32, [34] [35] [36] However, in these series, MRI scans were in most Correlation between hypometabolism and epileptogenic zone MRI location of intralesional electrodes, placed within the hypometabolic gyrus (S and R), ictal (A) and postictal (B) SEEG recordings, overall electrode placement view (C). Ictal onset zone corresponds to the hypometabolic gyrus, with a rapid low voltage discharge following a brief speeding of interictal spiking, as typically observed in Taylor-type focal cortical dysplasias. In addition, postictal depression of activity is well-localized in the same area. The patient is seizure-free for 22 months after a gyral resection.
instances positive, so the contribution of PET was not emphasized at this time. Although sensitivity of PET has been considered low in extratemporal cryptogenic epilepsies, ranging from 19% to 40%, 24, 36, 37 we found, in a preliminary study based on 100 patients with intractable partial epilepsy and negative MRI, visually assessed 18 FDG-PET to have a localizing value of 86%. 38 More recently, the usefulness of 18 FDG-PET was evaluated in a series of 45 patients with FCD, including 18 TTFCD cases. 39 In patients with negative MRI or subtle abnormal findings, increased sensitivity was obtained by overloading PET images on MRI, allowing detection of 98% of FCDs. However, in this series, PET was considered mainly useful in mild (type I) FCDs since all TTFCDs were detected by MRI. Another study reported for TTFCD detection similar sensitivity of both investigations, although 18 FDG-PET was slightly higher than MRI (93% vs 83%). 9 We show an impressive sensitivity of PET/MRI coregistration to detect TTFCDs, reaching 95%. We emphasize that despite high seizure frequency and occurrence of seizures during PET in some patients, we never observed hypermetabolism, whereas continuous interictal spiking generated by the dysplastic cortex should increase the metabolic demand. We hypothesize that abnormal giant cells that characterize TTFCD are unable to capture FDG during the interictal phase. Furthermore, seizures observed in TTFCD located in extratemporal areas are very short (usually less than 20 -30 seconds) and this is not sufficient to generate hypermetabolism since the steady state for FDG fixation is obtained 30 min after injection.
The better sensitivity of 18 FDG-PET in our series compared with previous reports may be explained by an increased intrinsic resolution of the PET camera. However, data analysis tools are also of importance. It has been mentioned that using colored scale and PET/MRI coregistration was helpful to detect mild FCDs. 39 We reach the same conclusion for TTFCDs, especially for small lesions deeply located in the medial aspect of the brain or at the bottom of the sulcus, where metabolism does not differ clearly from that of the white matter. SPM analysis, while not improving visual assessment, provides objective data and supports the localization value of the visually detected hypometabolism. Therefore, combination of visual PET/MRI coregistration and SPM procedure is recommended to improve the sensitivity of PET.
Although our study was not designed to evaluate 18 FDG-PET specificity, we emphasize that TTFCD is the most frequent histologic diagnosis for cryptogenic cases successfully treated by surgery. Furthermore, the extent of hypometabolic area and EZ was concordant in more than half the cases, corresponding to single isolated gyri. These findings have practical importance, since in these cases seizure freedom can be obtained by quite small resections, limited to the hypometabolic gyrus. Therefore, successful surgery may be safely performed even in central areas, avoiding permanent motor deficit. Interestingly, we found that these cases corresponded to very localized forms of TTFCDs always located at the bottom of the sulcus, as reported in 2 other studies focusing on small TTFCDs.
13, 40 We demonstrate here that such focal hypometabolism colocalized with a single gyrus corresponds to a "microscopic" form of TTFCDs and conclude that these cases must be considered for focal resection. For selected cases, it is even possible to avoid invasive monitoring, as for 2 of our patients.
Larger hypometabolic areas, corresponding to intralobar or multilobar cortical regions, also include TTFCD and EZ, but they are more extensive. Therefore, despite its less accurate value in regional than in focal cases, 18 FDG-PET is also helpful to guide the placement of intracranial electrodes and for presurgical planning. We assume that in such cases SEEG may remain indicated in order to limit the extent of the resection-an important consideration when planning surgical resection in eloquent cortex. However, such an invasive procedure may be progressively discontinued when multimodal imaging will be sufficient to delineate the dysplastic cortex. In this way, 18 FDG-PET coregistered with MRI appears particularly helpful, providing accurate information on TTFCD and EZ localization. We therefore recommend its systematic use in presurgical workup for neocortical cryptogenic epilepsy.
